Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Smoking Cessation 3Smoking 2Neoplasms 2Lung Neoplasms 2Alcohol Drinking 2Urinary Bladder Neoplasms 1Smokers 1Postoperative Complications 1HIV Infections 1Cigarette Smoking 1Cigarette Smoker 1Carcinoma, Non-Small-Cell Lung 1Cancer Free Women 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 346Cisplatin 240Paclitaxel 208Radiotherapy 207Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 147Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 102Etoposide 99Bevacizumab 96Specimen Handling 84Nivolumab 77Radiosurgery 74durvalumab 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 45Biopsy 43Radiation 42Irinotecan 42Topotecan 39Standard of Care 39Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lung Neoplasms × Smoking Devices × Clear all
NCT05304390 2024-12-02

A Tailored Screening and Smoking Cessation Program for the LGBTQ Community of Seattle

Fred Hutchinson Cancer Center

Phase NA Terminated
53 enrolled
Thoracic

Lung Neoplasms

NCT03642041 2018-08-22

Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients

National Defense Medical Center, Taiwan

Completed
406 enrolled
Thoracic

Cigarette Smoking, Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡